GLP-1 Weight Loss in New York (2026)

New York at a Glance

About GLP-1 Access in New York

New York is the largest city in the United States, located in New York with a population of approximately 8.3 million. Telehealth is legal in New York, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to New York ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The New York metro area brings the wider telehealth-serviceable population to roughly 19,500,000 residents, extending beyond the city's 8,336,817 city-proper population.

New York's adult obesity rate is approximately 27.3% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. New York has lower obesity prevalence than most states (#41 of 50), but telehealth still widens access beyond New York's major metros for New York residents who don't live near a specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

New York Medicaid covers GLP-1s for obesity with prior authorization, so New York residents on Medicaid should start by asking their prescriber to document a qualifying BMI and comorbidities for the PA request.

Looking beyond New York? See all GLP-1 providers in New York.

Browse by Medication

Browse all 331 providers with undisclosed coverage on the New York page →

In-Person vs Telehealth in New York

Patients in New York have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to New York addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in New York varies by plan^[4].

In-person weight-management clinics in New York (540 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly obesity medicine (preventive medicine), endocrinology, diabetes & metabolism.

• 180 Degrees Medical PLLC — Obesity Medicine (Preventive Medicine), 620 Malcolm X Blvd Apt 11D
• Aaron Schulman — Endocrinology, Diabetes & Metabolism, 525 E 68th St
• Aastha Pal — Endocrinology, Diabetes & Metabolism, 515 W 59th St Apt 28N
• Adi Cohen — Endocrinology, Diabetes & Metabolism, 180 Fort Washington Ave
• Adrienne Fleckman — Endocrinology, Diabetes & Metabolism, 350 E 17th St
• Agustin Busta — Endocrinology, Diabetes & Metabolism, 317 E 17th St
• Aida Saliby — Endocrinology, Diabetes & Metabolism, 317 E 17th St
• Akshan Puar — Endocrinology, Diabetes & Metabolism, 55 E 34th St FL 6

Browse all 540 New York clinics in the directory →

Cost of GLP-1 Medications in New York

Brand-name Wegovy in New York typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $229/month in New York, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Other Cities in New York

Comparing options beyond New York? GLP-1 telehealth providers ship statewide, so these New York cities have their own dedicated pricing and provider breakdowns:

Frequently Asked Questions